Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

German BMBF will fund new interdisciplinary research group looking at the subject of brain doping

29.01.2014
Joint project concerned with the complex transfer and exchange processes between researchers, physicians, journalists, and the general public

The transfer of knowledge on pharmacological neuroenhancement has become the focus of a new interdisciplinary research group at Johannes Gutenberg University Mainz (JGU).

Within the joint project "Pharmacological Neuroenhancement – Between Predictable Knowledge Transfer and Unintended Consequences" funded by the German Federal Ministry of Education and Research, Professor Klaus Lieb and Dr. Dr. Andreas G. Franke of the Department of Psychiatry and Psychotherapy, Professor Oliver Quiring of the Institute of Media and Communication Studies, and PD Dr. Elisabeth Hildt of the Department of Philosophy will be together exploring the complex transfer and exchange processes that occur between researchers, physicians, journalists, and the general public. Why do certain research findings reach the general population while others do not? Where do users get information about legal and prohibited substances? What role do physicians play when it comes to brain doping? And what influence do the media have? The aim of the Mainz-based academics is to systematically study knowledge transfer for the first time and analyze it in terms of its social impact. The project will run for a period of three years.

The rapid progress in modern neurotechnologies opens new and far-reaching opportunities for physicians to regulate and alter cerebral processes. The question of whether and to what extent drugs originally developed to treat diseases can and should also be used to improve the mental performance of healthy people has become a controversial subject. The so-called 'pharmacological neuroenhancers' have an enormous potential with regard to social impact and the commercial benefits for their manufacturers, but their availability has also generated new ethical, legal, and social concerns, one of the reasons being that the risks and effects associated with the use of these substances by healthy people are completely unknown.

Most of the substances used, such as methylphenidate (Ritalin®), amphetamines, and modafinil, are relatively easy to take and are apparently already being employed within certain social groups. As their clinical efficacy and undesirable effects together with the social and ethical implications are still unclear, communication of the scientific findings is particularly important from a social perspective.

Further information:
Professor Dr. Klaus Lieb
Department of Psychiatry and Psychotherapy
Mainz University Medical Center
D 55131 Mainz, GERMANY
phone +49 6131 17-7335
fax +49 6131-229974
e-mail: klaus.lieb@unimedizin-mainz.de
http://www.unimedizin-mainz.de/Psychiatrie [in German]
Professor Dr. Oliver Quiring
Institute of Media and Communication Studies
Johannes Gutenberg University Mainz
D 55099 Mainz, GERMANY
phone +49 6131 39-25222
fax +49 6131 39-24239
e-mail: quiring@uni-mainz.de
http://www.ifp.uni-mainz.de/241.php [in German]
PD Dr. Elisabeth Hildt
Department of Philosophy
Johannes Gutenberg University Mainz
D 55099 Mainz, GERMANY
phone +49 6131 39-24016
fax +40 6131-39-27402
e-mail: hildt@uni-mainz.de
http://www.blogs.uni-mainz.de/fb05philosophieengl/pd-dr-elisabeth-hildt/
Dr. Dr. Andreas G. Franke
Department of Psychiatry and Psychotherapy
Mainz University Medical Center
D 55131 Mainz, GERMANY
phone +49 6131 17-2920
fax +49 6131 17-6690
e-mail: afranke@uni-mainz.de

Petra Giegerich | idw
Further information:
http://www.uni-mainz.de/presse/16923_ENG_HTML.php
http://www.unimedizin-mainz.de/psychiatrie/patienten/ansprechpartner/lebenslauf/franke.html

More articles from Awards Funding:

nachricht Six German-Russian Research Groups Receive Three Years of Funding
12.09.2017 | Hermann von Helmholtz-Gemeinschaft Deutscher Forschungszentren

nachricht IVAM Marketing Prize recognizes convincing technology marketing for the tenth time
22.08.2017 | IVAM Fachverband für Mikrotechnik

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>